Not Yet RecruitingNot Applicable

Resilience-Building for Advance Care Planning

152 participantsStarted 2026-03-20

Plain-language summary

The aims of this study are to (1) assess the feasibility, acceptability, and usability of the ROCKS intervention among patients with advanced cancer and their family caregivers through a randomized controlled trial in a cancer center setting; (2) evaluate the preliminary efficacy of ROCKS, as compared to usual care, on changes in completion of advance directives; and (3) explore the dyadic effects of resilience on self-efficacy, optimism, dyadic communication and coping, anxiety, and depression using an actor-partner interdependence model.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Eligible patients will (1) be ≥ 18 years of age; (2) be diagnosed with stage 3 or 4 cancer; and (3) have a family caregiver who is willing to participate. * Eligible family caregivers will be ≥ 18 years of age. All participants must be able to read, write, and speak English with minimal assistance from others and have access to the internet on a smartphone, laptop, or computer. Exclusion Criteria: * Patient participants will be ineligible if they have (1) a Short Portable Mental Status Questionnaire (SPMSQ) score \< 8; or (2) have completed any form of advance directive.

What they're measuring

Completion of advance directives

Timeframe: Week 8

Trial details

NCT IDNCT07428278

SponsorUniversity of Illinois at Chicago

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-05-31

Contact for this trial

Li-Ting Longcoy

312-996-3024 liting@uic.edu

View on ClinicalTrials.gov More Advanced Cancer trials